Home / Companies / Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. / 9 Dec 2025
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.: meeting of 9 Dec 2025
Votes reported on Form N-PX, item by item
40 Form N-PX filers reported votes at the Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. meeting of 9 Dec 2025. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
1 nominee; 100.0% of reported votes for; no filer withheld from or voted against at least one nominee.
22 vote records from 9 filers. 0 of the 9 filers that marked the item either way voted against management.
DIRECTOR ELECTIONSSecurity holder
Director elections (nominees put forward by security holders)
1 nominee; 100.0% of reported votes for; no filer withheld from or voted against at least one nominee.
54 vote records from 31 filers. 0 of the 31 filers that marked the item either way voted against management.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
304 vote records from 40 filers. 38 of the 40 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 2. Directors |
|---|---|---|
| Vanguard | No report | For |
| BlackRock and iShares | For | No report |
| Fidelity | No report | For |
| Dimensional | No report | For |
| State Street and SPDR | No report | For |
| Franklin Templeton | No report | For |
| Equitable | No report | For |
| Charles Schwab | For | No report |
| Nuveen and TIAA | No report | For |
| ProShares and ProFunds | No report | For |
| John Hancock and Manulife | For | No report |
| Morgan Stanley, Eaton Vance and Calvert | No report | For |
| J.P. Morgan | No report | For |
| Goldman Sachs | No report | For |
| Jackson National funds | For | No report |
| Northern Trust and FlexShares | No report | For |
| Lincoln Financial | No report | For |
| Voya | No report | For |
| BNY Mellon | No report | For |
| Pacific Life funds | No report | For |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. meeting?
40 Form N-PX filers reported votes at the meeting of 9 Dec 2025. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. with a meeting date within three days of 9 Dec 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.